Three Natchez students earn top academic honors at William Carey University’s Fall 2025 term, landing spots on the elite ...

“The Dreamin’ Kind” is Langhorne Slim’s ninth studio album and finds the Pennsylvania-born, Nashville-based artist strapping on an electric guitar and embracing his longtime love of larger-than-life ...

In her Tuesday newsletter, Lily Belli notes a reshuffling at downtown Santa Cruz's Abbott Square Market, reviews the new ...

Business owners Michael Spadafora and Patrice Boyle reflect on a tumultuous year for their businesses as the Murray Street ...

Ian Bishop makes a sharp observation! Bishop explains why batters are often celebrated as heroes while bowlers play the ...

Alpha Wealth Funds, LLC, an investment management company, released its Q3 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here. The fund returned 4.96% in September, ...

Its lineup and pipeline put it well ahead of even its closest competitor. The drugmaker should continue riding this wave for the foreseeable future. Furthermore, Novo Nordisk is anticipating ...

Eli Lilly (LLY) has shown considerable rally potential, with several occurrences of its stock climbing over 30% in less than two months. Remarkably, it achieved rallies exceeding 50% on two occasions, ...

Eli Lilly stock was on the outside looking in on Tuesday as shares of Novo Nordisk, its rival in diabetes and weight-loss drugs, soared after the company secured regulatory approval for a weight-loss ...

What To Know: Novo Nordisk, one of Eli Lilly’s main competitors, announced a regulatory breakthrough for an oral weight loss drug. The FDA approved the company’s pill form of Wegovy, making it the ...

Aktis Oncology (AKTS), a radiopharmaceutical drug developer backed by pharma giants such as Eli Lilly (LLY), has filed its preliminary regulatory filings with the Securities and Exchange Commission ...